• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine.

作者信息

McCann U D, Eligulashvili V, Ricaurte G A

机构信息

Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, MD, USA.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 1998 Oct;22(7):1087-102. doi: 10.1016/s0278-5846(98)00063-3.

DOI:10.1016/s0278-5846(98)00063-3
PMID:9829290
Abstract
  1. There is a large body of evidence indicating that fenfluramines damage brain serotonin neurons in animals. 2. Little is known about potential adverse neuropsychiatric consequences in humans associated with use of fenfluramines that could potentially be related to serotonergic dysfunction. 3. The authors now report numerous cases of severe and, sometimes persistent, neuropsychiatric syndromes associated with fenfluramine use. 4. Thirty one representative cases are presented and summarized in table form. 5. Several of the cases presented suggest long-lasting deleterious effects of fenfluramines on brain serotonin function. 6. Clinicians should be vigilant for disorders of mood, anxiety, cognitive function and impulse control in patients previously exposed to fenfluramines.
摘要

相似文献

1
Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine.
Prog Neuropsychopharmacol Biol Psychiatry. 1998 Oct;22(7):1087-102. doi: 10.1016/s0278-5846(98)00063-3.
2
Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.曾接受右芬氟拉明或苯丁胺/芬氟拉明治疗的患者的临床及超声心动图随访
JAMA. 2001;286(16):2011-4. doi: 10.1001/jama.286.16.2011.
3
Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.服用右芬氟拉明或苯丙胺/芬氟拉明后出现的瓣膜异常及心血管状况
JAMA. 2000 Apr 5;283(13):1703-9. doi: 10.1001/jama.283.13.1703.
4
Appetite-suppressing drugs and valvular heart disease.食欲抑制药物与心脏瓣膜病
Cardiol Rev. 1999 Nov-Dec;7(6):356-61. doi: 10.1097/00045415-199911000-00014.
5
Operation for anorexigen-associated valvular heart disease.与食欲抑制相关的瓣膜性心脏病手术。
J Thorac Cardiovasc Surg. 2001 Oct;122(4):656-64. doi: 10.1067/mtc.2001.116315.
6
Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.芬氟拉明和右芬氟拉明导致的脑血清素神经毒性与原发性肺动脉高压。证据的系统评价
JAMA. 1997 Aug 27;278(8):666-72.
7
Heart valve disorders and appetite-suppressant drugs.心脏瓣膜疾病与食欲抑制药物。
JAMA. 2000 Apr 5;283(13):1738-40. doi: 10.1001/jama.283.13.1738.
8
Quantitative positron emission tomography studies of the serotonin transporter in humans previously treated with the appetite suppressants fenfluramine or dexfenfluramine.
Mol Imaging Biol. 2007 May-Jun;9(3):151-7. doi: 10.1007/s11307-007-0082-7.
9
Too late, again?又太晚了?
Can Respir J. 2001 May-Jun;8(3):127-8. doi: 10.1155/2001/234871.
10
Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine.服用芬氟拉明-苯丙胺复方制剂或右芬氟拉明的患者中二尖瓣和/或主动脉瓣反流的超声心动图患病率。
Am J Cardiol. 1999 Dec 1;84(11):1335-8. doi: 10.1016/s0002-9149(99)00567-6.

引用本文的文献

1
Neuropsychiatric adverse effects of centrally acting antiobesity drugs.中枢作用减肥药的神经精神不良反应。
CNS Neurosci Ther. 2011 Oct;17(5):490-505. doi: 10.1111/j.1755-5949.2010.00172.x. Epub 2010 Jul 7.
2
Safety of drug therapies used for weight loss and treatment of obesity.用于减肥和肥胖症治疗的药物疗法的安全性。
Drug Saf. 2006;29(4):277-302. doi: 10.2165/00002018-200629040-00001.
3
Serotonin neurotoxins--past and present.血清素神经毒素——过去与现在
Neurotox Res. 2004;6(7-8):589-614. doi: 10.1007/BF03033455.